Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 2/2011

01.02.2011 | Materno-fetal Medicine

Pregnancy and postpartum specifics in women with schizophrenia: a meta-study

verfasst von: Naira Roland Matevosyan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

This meta-study intends to elucidate schizophrenia–pregnancy inferences.

Methods

A total of 63 quasi-randomized, case–control, linkage studies on outcomes of singleton pregnancies in women with schizophrenia are identified through PubMed, ACOG, and SCOPUS. A sample of 216 pregnant and puerperal women with schizophrenia, allocated from studies of level I–IIA evidence, is compared with a sample of 487 births to unaffected women. Calculations use births as unit of analysis. Poisson regression model is used in exchangeable correlation structure.

Results

Older age (2.13), excessive smoking (1.85) and less antenatal care (1.92) in women with schizophrenia determine high risk for prematurity (2.08), including miscarriages (2.04) and preterm birth (1.98). Neonates to mothers with schizophrenia are profiled with twice likelihood of low Apgar scores (2.22), intrauterine growth retardation (2.16), and congenital defects (2.1). Poor maternal–fetal attachment and preoccupation about fetus are related to negative symptoms of schizophrenia (−0.518), length of antipsychotic treatment (−0.304) and are not associated with maternal age (0.216). Postpartum period is eventful with psychotic relapse (7.86), and parenting difficulties (11.2).

Conclusions

After adjusting for age, parity, unhealthy behaviors, length of antipsychotic treatment, and maternal–fetal attachment, maternal schizophrenia remains predictive to prematurity and postpartum psychosis.
Literatur
1.
Ahern N, Ruland JP (2003) Maternal–fetal attachment. J Perinat Educ 12(4):27–35PubMed
2.
Aichhorn W, Stuppaeck C, Whitworth AB (2005) Risperidone and breast-feeding. J Psychopharmacol 19:211–213CrossRefPubMed
3.
Alhusen JL (2008) A literature update on maternal–fetal attachment. J Obstet Gynecol Neonat Nurs 37(3):315–328CrossRef
4.
Altshuler LL, Cohen L, Szuba MP et al (1996) Pharmacological management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153:592–606PubMed
5.
Bennedsen BE, Mortensen PB, Olesen AV et al (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatry 175:239–245CrossRefPubMed
6.
Bennedsen BE, Mortensen PB, Olesen AV et al (2001) Obstetric complications in women with schizophrenia. Schizophr Res 47(203):167–175CrossRefPubMed
7.
Condon JT (1993) The assessment of antenatal emotional attachment: development of a questionnaire instrument. Br J Med Psychol 66(pt 2):167–183PubMed
8.
Cranley MS (1981) Development of a tool for the measurement of maternal attachment during pregnancy. Nurs Res 30:281–284CrossRefPubMed
9.
Dev V, Krupp P (1995) Adverse event profile and safety of clozapine. Rev Contemp Pharmacother 6:197–208
10.
Dudzinski DM, Sullivan M (2004) When agreeing with the patient is not enough: a schizophrenic woman requests pregnancy termination. Law Ethics Psychiatry
11.
Ellman LN, Huttenen M, Lönnqvist J et al (2007) The effects of genetic liability for schizophrenia and maternal smoking during pregnancy on obstetrical complications. Schizophr Res 93(1–3):229–236CrossRefPubMed
12.
Field MA (1989) Controlling the woman to protect the fetus. Law Med Health Care 17(2):114–129PubMed
13.
Gardiner SJ, Kristensen JH, Begg EJ et al (2003) Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 160:1428–1431CrossRefPubMed
14.
Hendrick V (2006) Psychiatric disorders in pregnancy and the postpartum: principles and treatment. (Current Clinical Practice Series) Hardcover, Humana Press
15.
Hill RC, McIvor RJ, Wojnar-Horton RE et al (2000) Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J Clin Psychopharmacol 20:285–286CrossRefPubMed
16.
Hizkiyahu R, Levy A, Sheiner E (2009) Pregnancy outcome of patients with schizophrenia. Am J Perinatol 27(1):19–23CrossRefPubMed
17.
Howard LM, Kumar R, Thornicroft G (2001) Psychosocial characteristics and needs of mothers with psychotic disorders. Br J Psychiatry 178:427–432CrossRefPubMed
18.
Howard LM (2005) Fertility and pregnancy in women with psychotic disorders. Eur J Obstetrics Gynecology Reprod Biol 119:3–10CrossRef
19.
Hultman CM, Cnattingius S, Olausson PO et al (2008) Schizophrenia and offspring’s risk for adverse pregnancy outcomes and infant death. Br J Psychiatry 193:311–315CrossRefPubMed
20.
Ilett KF, Hackett LP, Kristensen JH et al (2004) Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother 38:273–276CrossRefPubMed
21.
Jablensky AV, Morgan V, Soc MS et al (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 162:79–91CrossRefPubMed
22.
Jeffries JJ, Plummer E, Thornton JF, Seeman MV (1999) Living and working with schizophrenia, 2nd edn, Hardcover
23.
King-Hele SA, Abel KM, Webb RT et al (2007) Risk of sudden infant death syndrome with parental mental illness. Arch Gen Psychiatry 64(11):1323–1330CrossRefPubMed
24.
Kolder VE, Gallagher J (1987) Court-ordered obstetrical interventions. N Engl J Med 316(19):1192–1196CrossRefPubMed
25.
Kotlicka AM, Gmitrowitcz A, Sobow TM et al (2001) Obstetrical complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms. J Psychiatr Res 35(4):249–257CrossRef
26.
Lee HC, Lin HC (2009) Maternal bipolar disorder increased low birth weight and preterm births: a nationwide population-based study. J Affect Disord 121(1–2):100–105PubMed
27.
Lee A, Giesbrecht E, Dunn E et al (2004) Excretion of quetiapine in breast milk. Am J Psychiatry 161:1715–1716CrossRefPubMed
28.
Lerum CW, LoBiondo-Wood G (1989) The relationship of maternal age, quickening, and physical symptoms of pregnancy to the development of maternal–fetal attachment. Birth 16:13–17CrossRefPubMed
29.
Lin HC, Chen IJ, Chen YH et al (2010) Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophr Res 116(1):55–60CrossRefPubMed
30.
Lindgren K (2001) Relationships among maternal-fetal attachment, prenatal depression, and health practices in pregnancy. Res Nurs Health 24(3):203–217CrossRefPubMed
31.
Maret SM (1989) Frank Lake’s maternal–fetal distress syndrome:—an analysis, Chap. 3, Caldwell University, Caldwell
32.
Maskenzie TB, Nagel TC (1986) When a pregnant woman endangers her fetus. Hastings Center Report 16(1):24–25CrossRef
33.
McIntosh AM, Homes S, Gleeson S et al (2002) Maternal recall bias, obstetric history and schizophrenia. Br J Psychiatry 181:520–525CrossRefPubMed
34.
Miller LJ, Shah A (1999) Major mental illness during pregnancy. Primary Care Update for OB/GYNS 6(5, 10):163–168
35.
Miller LJ (2007) Comprehensive care of pregnant mentally ill women. J Behav Health Serv Res
36.
Miller LJ (1997) Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr Bull 23(4):623–635PubMed
37.
McK. Doan H, Cox NL et al (2003) The maternal fetal attachment scale: some methodological pondering. J Prenat Perinat Psychol Health 18(2):167–188
38.
Muller ME (1993) Development of the prenatal attachment inventory. Western J Nurs Res 15:199–215CrossRef
39.
Nilsson E, Lichtenstein P, Cnattingius S et al (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 58:221–229CrossRefPubMed
40.
Ogle A, Mazzullo L (2002) Before your pregnancy: a 90 day guide for couples on how to prepare for a healthy conception, Hardcover
41.
Ostler T (2009) Mental illness in peripartum period. Zero to Three 29(5)
42.
Pinkerton JV, Finerty JJ (1996) Resolving the clinical and ethical dilemmas involved in fetal–maternal conflicts. Am J Obstet Gynecol 175(2):289–295CrossRefPubMed
43.
Preti A, Cardascia L, Zen T et al (2000) Risk for obstetric complications and schizophrenia. Psychiatry Res 96(2):127–139CrossRefPubMed
44.
Righetti PL, Dell’Avanzo M, Grigio M et al (2005) Maternal/paternal antenatal attachment and fourth-dimensional ultrasound technique: a preliminary report. Br J Psychol 96(Pt 1):129–137CrossRefPubMed
45.
Riley D (1995) Perinatal mental health, Hardcover. Radcliffe Medical Press, Oxford
46.
47.
Schneid-Kofman N, Sheiner E, Levy A (2008) Psychiatric illness and adverse pregnancy outcome. Int J Gynecol Obstet 101(1):53–56CrossRef
48.
Schubert EW, Blennow G, McNeil TF (1996) Wakefulness and arousal in neonates born to women with schizophrenia: diminished arousal and its association with neurological deviations. Schizophr Res 22(1):49–59CrossRefPubMed
49.
Spinelli MG (2004) Maternal infanticide associated with mental illness: prevention and the promise of saved lives. Am J Psychiatry 161:1548–1557CrossRefPubMed
50.
Susser ES, Gorman JM, Brown AS (1999) Prenatal exposures in schizophrenia, vol 56, Hardcover, American Psychiatric Publishing
51.
Tsai-Ching L, Chin-Shyan C, Chung Ping AL (2009) Do children of parents with mental illness have lower survival rate? A population-based study. Comprehensive psychiatry (in press)
52.
Van Bogaert LJ (2006) Rights of and duties to non-consenting patients—informed refusal in the developing world. Develop World Bioethics 6(1):13–22CrossRef
53.
Wan MW, Moulton S, Abel KM (2008) A review of mother–child relational interventions and their usefulness for mothers with schizophrenia. Arch Womens Mental Health 11(3):171–179CrossRef
54.
Yaeger D, Smith HG, Altshuler LL (2006) Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum. Am J Psychiatry 163:2064–2070CrossRefPubMed
55.
Yarcheski A, Mahon NE, Yarcheski TJ et al (2009) A meta-analytic study of predictors of maternal-fetal attachment. Int J Nurs Studies 46(5):708–715
56.
Yaris F, Yaris E, Kadioglu M et al (2004) Use of polypharmacotherapy in pregnancy: a prospective outcome in a case. Prog Neuropsychopharmacol Biol Psychiatry 28(3):603–605CrossRefPubMed
57.
Yun Y, Phillips LJ, Cotton S et al (2005) Obstetric complications and transition to psychosis in an ‘ultra’ high risk sample. Aust N Zealand J Psychiatry 39(6):460–466
58.
Zammit S, Allebeck P, Dalman C et al (2003) Paternal age and risk for schizophrenia. Br J Psychiatry 183:405–408CrossRefPubMed
59.
Zammit S, Lewis S, Gunnell D (2007) Schizophrenia and neural tube defects: comparisons from an epidemiological perspective. Schizophr Bull 33(4):853–858CrossRefPubMed
60.
Zax M, Sameroff AJ, Babijian HM (1977) Birth outcomes in the offspring of mentally disordered women. Am J Orthopsychiatry 47(2):218–230CrossRefPubMed
61.
Zimerman A, Doan H, McK (2003) Prenatal attachment and other feelings and thoughts during pregnancy in three groups of pregnant women. J Prenatal Perinatal Psychol Health 18(2):131–148
62.
Zipursky RB, Schulz SC (1987) Seasonality of birth and CT findings in schizophrenia. Biol Psychiatry 22(10):1288–1292CrossRefPubMed
63.
Zornberg GL, Buka SL, Tsuang MT (2000) The problem of obstetrical complications and schizophrenia. Schizophr Bull 26(2):249–256PubMed
Metadaten
Titel
Pregnancy and postpartum specifics in women with schizophrenia: a meta-study
verfasst von
Naira Roland Matevosyan
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1706-8

Weitere Artikel der Ausgabe 2/2011

Archives of Gynecology and Obstetrics 2/2011 Zur Ausgabe

Materno-fetal Medicine

Effect of milk and calcium supplementation on bone density and bone turnover in pregnant Chinese women: a randomized controlled trail

Erratum

Erratum to: Development of fetal brain sulci and gyri: assessment through two and three-dimensional ultrasound and magnetic resonance imaging

Gynecologic Oncology

Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes

Letter to the Editor

Precipitous delivery after induction of combined spinal epidural analgesia

Gynecologic Oncology

Combined positron emission tomography–computed tomography and tumor markers for detecting recurrent ovarian cancer

Materno-fetal Medicine

Inhibin/activin-betaE subunit is expressed in normal and pathological human placental tissue including chorionic carcinoma cell lines

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise